학술논문

Azathioprine in steroid refractory immune checkpoint inhibitor-induced cholangitis: a case report / アザチオプリン導入にて改善を認めたステロイド不応性irAE(immune-related adverse event)胆管炎の1例
Document Type
Journal Article
Source
胆道 / Tando. 2020, 34(2):223
Subject
cholangitis
immune-related adverse events
immunosuppressive agents
免疫抑制剤
胆管炎
Language
Japanese
ISSN
0914-0077
1883-6879
Abstract
A 61-year-old man had received 15 cycles of nivolumab, and he was treated with docetaxel for an advanced lung squamous cell carcinoma. Two months later after the final injection of nivolumab, he presented with epigastralgia. Laboratory test showed cholestasis. Abdominal computed tomography with contrast medium showed diffuse wall thickening of extrahepatic duct and ampulla of vater. Endoscopic retrograde cholangiography showed extrahepatic bile duct dilation without obstruction. Histological findings of bile duct biopsy confirmed severe infiltration of lymphocyte, dominantly composed of CD8+Tcell in subepithelial tissue. We made the diagnosis of immune checkpoint inhibitor-induced cholangitis by these findings. Because he did not respond to the initial systemic corticosteroid therapy and additional treatment of mycophenolate mofetil, we treated with azathioprine. Cholestasis improved after the administration of azathioprine, then we restarted chemotherapy.

Online Access